Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-07

Clinical Trial Update: CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing crushed versus uncrushed prasugrel in STEMI patients undergoing PCI has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRASUGREL (prasugrel)

Snippet

Sponsor: Maasstad Hospital | Conditions: Cardiovascular Diseases | Phase 4 | Status: COMPLETED